APOSAN

Koln, Germany Acquired By IK Partners
Rehabilitation services are provided to patients in Cologne, Germany.

About APOSAN

APOSAN is a Healthcare company based in Koln (Germany), and was acquired by IK Partners in October 2016. Rehabilitation services are provided to patients in Cologne, Germany. It operates on a Managed Services and HealthTech model. APOSAN offers products and services including Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition. Its focus areas include Medical Services and Home Care Services. Its legal entity is APOSAN GmbH.

Company details

APOSAN is focused on delivering ambulatory medication therapies tailored for home application. Specialized solutions are provided in areas such as parenteral antibiotic therapy, parenteral and enteral nutrition, and treatments for conditions like age-related macular degeneration and cystic fibrosis. Services are extended to patients, healthcare providers, hospitals, pharmacies, and care facilities across Germany. Comprehensive patient care and support are ensured to enable independent therapy management in familiar surroundings. The company operates within the healthcare sector, emphasizing personalized infusion solutions and holistic care concepts.

  • Headquarters Koln, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website aposan.de
  • Social LinkedIn YouTube
  • Acquired by IK Partners (Oct 2016)
  • Legal Name Aposan Gmbh
Key Metrics

Products & Services of APOSAN

APOSAN offers a comprehensive portfolio of products and services, including Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition.

Ambulatory Parenteral Antibiotic Therapy (APAT)
Healthcare Services

Parenteral antibiotic therapy is provided for home use.

Parenteral Nutrition
Healthcare Services

Customized nutritional infusions are prepared for home therapy.

Enteral Nutrition
Healthcare Services

Nutritional support is offered through enteral feeding solutions.

Apps and channels of APOSAN

its YouTube channel APOSAN has 411 subscribers and 16 videos.

APOSAN
YouTube 411 subscribers 16 videos Film & Animation
Open channel

Videos from APOSAN

The most watched videos on APOSAN's YouTube channel, APOSAN (411 subscribers). Click a video to play it here.

APOSAN – parenterale Ernährungstherapie zu Hause
20.7K views
Anwendung von sterilen Fertigspritzen mit VEGF Antagonisten in der ophthalmochirugischen Praxis
7.7K views
APOSAN - Infusionstherapie Zuhause
6.6K views
APOSAN - Überleitungsmanagement für ambulante Infusionstherapien - einfach erklärt
6.2K views

More on APOSAN.

Investors in APOSAN

APOSAN has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IK Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments are directed toward small and medium-sized businesses.
1989ikpartners.comAmsterdam, Netherlands
Premium access

Investor details for APOSAN

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of APOSAN

3 people are tracked at APOSAN (3 in leadership).

NameRoleGroup
Rainer Schmitz
Managing DirectorLeadership
Michael Schmitz
Managing DirectorLeadership
Susanne Roeb
Managing Director / Qualified PersonLeadership
Premium access

Complete people profiles for APOSAN

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of APOSAN

The website of APOSAN (aposan.de) receives about 3.8K visits a month.

  • Monthly visits
    3.8K

    ▲ 6.9% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about APOSAN

APOSAN is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

APOSAN is focused on delivering ambulatory medication therapies tailored for home application. Specialized solutions are provided in areas such as parenteral antibiotic therapy, parenteral and enteral nutrition, and treatments for conditions like age-related macular degeneration and cystic fibrosis. Services are extended to patients, healthcare providers, hospitals, pharmacies, and care facilities across Germany. Comprehensive patient care and support are ensured to enable independent therapy management in familiar surroundings. The company operates within the healthcare sector, emphasizing personalized infusion solutions and holistic care concepts.

APOSAN offers Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition.

APOSAN has 1 investor. Key investors include IK Partners.

APOSAN operates through Aposan Gmbh.

Yes. APOSAN was acquired by IK Partners in October 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available